Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Chembiochem ; 12(17): 2677-85, 2011 Nov 25.
Article in English | MEDLINE | ID: mdl-21953874

ABSTRACT

Coumermycin A(1) is an aminocoumarin antibiotic produced by Streptomyces rishiriensis. It contains three pyrrole rings, that is, two terminal 5-methyl-pyrrole-2-carboxyl moieties and a central 3-methylpyrrole-2,4-dicarboxylic acid moiety. The biosynthesis of the terminal pyrrole moieties has been elucidated previously. However, the biosynthetic precursors of the central pyrrole moiety have remained unknown, and none of the genes or enzymes involved in its formation has been identified. We now show that five genes, contained in a contiguous 4.7 kb region within the coumermycin biosynthetic gene cluster, are required for the biosynthesis of this central pyrrole moiety. Each of these genes was deleted individually, resulting in a strong reduction or an abolishment of coumermycin production. External feeding of the central pyrrole moiety restored coumermycin production. One of these genes shows similarity to L-threonine kinase genes. Feeding of [U-(13)C,(15) N]L-threonine and (13)C NMR analysis of the resulting compound unequivocally proved that threonine was incorporated intact into the central pyrrole (19 % enrichment) to provide the heterocyclic nitrogen as well as four of the seven carbons of this moiety. Therefore, this pyrrole is formed via a new, hitherto unknown biosynthetic pathway. A hypothesis for the reaction sequence leading to the central pyrrole moiety of coumermycin A(1) is presented.


Subject(s)
Aminocoumarins/metabolism , Anti-Bacterial Agents/biosynthesis , Pyrroles/metabolism , Threonine/metabolism , Aminocoumarins/chemistry , Anti-Bacterial Agents/chemistry , Carbon Isotopes/chemistry , Magnetic Resonance Spectroscopy , Multigene Family , Pyrroles/chemistry , Streptomyces/genetics , Streptomyces/metabolism
2.
Chembiochem ; 12(3): 477-87, 2011 Feb 11.
Article in English | MEDLINE | ID: mdl-21290549

ABSTRACT

Napsamycins are potent inhibitors of bacterial translocase I, an essential enzyme in peptidoglycan biosynthesis, and are classified as uridylpeptide antibiotics. They comprise an N-methyl diaminobutyric acid, an ureido group, a methionine and two non-proteinogenic aromatic amino acid residues in a peptide backbone that is linked to a 5'-amino-3'-deoxyuridine by an unusual enamide bond. The napsamycin gene cluster was identified in Streptomyces sp. DSM5940 by using PCR probes from a putative uridylpeptide biosynthetic cluster found in S. roseosporus NRRL15998 by genome mining. Annotation revealed 29 hypothetical genes encoding for resistance, regulation and biosynthesis of the napsamycins. Analysis of the gene cluster indicated that the peptide core structure is assembled by a nonlinear non-ribosomal peptide synthetase (NRPS)-like mechanism that involves several discrete single or didomain proteins. Some genes could be assigned, for example, to the synthesis of the N-methyl diaminobutyric acid, to the generation of m-tyrosine and to the reduction of the uracil moiety. The heterologous expression of the gene cluster in Streptomyces coelicolor M1154 resulted in the production of napsamycins and mureidomycins as demonstrated by LC-ESI-MS and MS/MS analysis. The napsamycin gene cluster provides a molecular basis for the detailed study of the biosynthesis of this class of structurally unusual compounds.


Subject(s)
Anti-Bacterial Agents/biosynthesis , Multienzyme Complexes/genetics , Peptides/metabolism , Amino Acid Sequence , Anti-Bacterial Agents/chemistry , Antimicrobial Cationic Peptides , Chromatography, High Pressure Liquid , Cloning, Molecular , Genome, Bacterial , Multienzyme Complexes/metabolism , Multigene Family , Nucleosides/biosynthesis , Nucleosides/chemistry , Peptide Synthases/genetics , Peptide Synthases/metabolism , Peptides/chemistry , Spectrometry, Mass, Electrospray Ionization , Streptomyces/enzymology , Streptomyces/genetics , Tyrosine/metabolism , Uracil/chemistry
3.
Rapid Commun Mass Spectrom ; 25(4): 495-502, 2011 Feb 28.
Article in English | MEDLINE | ID: mdl-21259358

ABSTRACT

The development of reliable analytic methods, capable of separating mixtures of secondary metabolites as well as providing structural information, is essential for the investigation of secondary metabolites, e.g. from Streptomyces. Here we report a liquid chromatography/electrospray ionization tandem mass spectrometry (LC/ESI-MS/MS) method using a triple quadrupole mass analyzer for the structural elucidation of caprazamycins and liposidomycins from culture extracts of the wild-type producer strains. Comparison of the fragmentation patterns in positive as well as in negative ionization mode revealed several characteristic product ions used for identification of six new caprazamycins. Furthermore, a chromatographic method for the purification of nucleosides from cell cultures using a boronic acid gel was adapted for the partial purification of the culture extracts.


Subject(s)
Azepines/chemistry , Chromatography, High Pressure Liquid/methods , Tandem Mass Spectrometry/methods , Uridine/analogs & derivatives , Aminoglycosides/chemistry , Azepines/classification , Culture Media , Fermentation , Streptomyces/metabolism , Uridine/chemistry , Uridine/classification
4.
Biopolymers ; 93(9): 823-32, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20578003

ABSTRACT

The biosynthetic gene clusters of the aminocoumarin antibiotics clorobiocin and coumermycin A(1) and of the liponucleoside antibiotic caprazamycin were stably integrated into the genomes of different host strains derived from Streptomyces coelicolor A3(2). For the heterologous expression of clorobiocin derivatives in a chemically defined medium, inclusion of 0.6% of the siloxylated ethylene oxide/propylene oxide copolymer Q2-5247 into the growth medium proved to result in a 4.8-fold increase of productivity. Presumably, this copolymer acts as an oxygen carrier. The additional inclusion of cobalt chloride (0.2-2 mg l(-1)) dramatically increased the percentage of the desired compound clorobiocin within the total produced clorobiocin derivatives. This is very likely due to a stimulation of a cobalamin-dependent methylation reaction catalyzed by the enzyme CloN6 of clorobiocin biosynthesis. All three investigated host strains (S. coelicolor M512, M1146 and M1154) gave similar production rates of total clorobiocin derivatives (on average, 158 mg l(-1) in the presence of 0.6% Q2-5247 and 0.2 mg l(-1) CoCl(2)). In contrast, heterologous production of caprazamycin derivatives was optimal in strain M1154 (amounts of 152 mg l(-1) on average).


Subject(s)
Azepines/metabolism , Gene Expression , Genes, Bacterial , Multigene Family , Novobiocin/analogs & derivatives , Streptomyces coelicolor/metabolism , Aminocoumarins/metabolism , Novobiocin/biosynthesis , Streptomyces coelicolor/genetics
5.
Appl Environ Microbiol ; 76(12): 4008-18, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20418426

ABSTRACT

Caprazamycins are antimycobacterials produced by Streptomyces sp. MK730-62F2. Previously, cosmid cpzLK09 was shown to direct the biosynthesis of caprazamycin aglycones, but not of intact caprazamycins. Sequence analysis of cpzLK09 identified 23 genes involved in the formation of the caprazamycin aglycones and the transfer and methylation of the sugar moiety, together with genes for resistance, transport, and regulation. In this study, coexpression of cpzLK09 in Streptomyces coelicolor M512 with pRHAM, containing all the required genes for dTDP-l-rhamnose biosynthesis, led to the production of intact caprazamycins. In vitro studies showed that Cpz31 is responsible for the attachment of the l-rhamnose to the caprazamycin aglycones, generating a rare acylated deoxyhexose. An l-rhamnose gene cluster was identified elsewhere on the Streptomyces sp. MK730-62F2 genome, and its involvement in caprazamycin formation was demonstrated by insertional inactivation of cpzDIII. The l-rhamnose subcluster was assembled with cpzLK09 using Red/ET-mediated recombination. Heterologous expression of the resulting cosmid, cpzEW07, led to the production of caprazamycins, demonstrating that both sets of genes are required for caprazamycin biosynthesis. Knockouts of cpzDI and cpzDV in the l-rhamnose subcluster confirmed that four genes, cpzDII, cpzDIII, cpzDIV, and cpzDVI, are sufficient for the biosynthesis of the deoxysugar moiety. The presented recombineering strategy may provide a useful tool for the assembly of biosynthetic building blocks for heterologous production of microbial compounds.


Subject(s)
Antitubercular Agents/metabolism , Biosynthetic Pathways/genetics , Multigene Family , Streptomyces coelicolor/genetics , Streptomyces coelicolor/metabolism , Uridine/analogs & derivatives , Azepines , DNA, Bacterial/chemistry , DNA, Bacterial/genetics , Deoxy Sugars/metabolism , Gene Knockout Techniques , Genes, Bacterial , Genetic Engineering , Molecular Sequence Data , Mutagenesis, Insertional , Sequence Analysis, DNA , Uridine/biosynthesis
6.
J Biol Chem ; 285(17): 12684-94, 2010 Apr 23.
Article in English | MEDLINE | ID: mdl-20157116

ABSTRACT

Sulfotransferases are involved in a variety of physiological processes and typically use 3'-phosphoadenosine 5'-phosphosulfate (PAPS) as the sulfate donor substrate. In contrast, microbial arylsulfate sulfotransferases (ASSTs) are PAPS-independent and utilize arylsulfates as sulfate donors. Yet, their genuine acceptor substrates are unknown. In this study we demonstrate that Cpz4 from Streptomyces sp. MK730-62F2 is an ASST-type sulfotransferase responsible for the formation of sulfated liponucleoside antibiotics. Gene deletion mutants showed that cpz4 is required for the production of sulfated caprazamycin derivatives. Cloning, overproduction, and purification of Cpz4 resulted in a 58-kDa soluble protein. The enzyme catalyzed the transfer of a sulfate group from p-nitrophenol sulfate (K(m) 48.1 microM, k(cat) 0.14 s(-1)) and methyl umbelliferone sulfate (K(m) 34.5 microM, k(cat) 0.15 s(-1)) onto phenol (K(m) 25.9 and 29.7 mM, respectively). The Cpz4 reaction proceeds by a ping pong bi-bi mechanism. Several structural analogs of intermediates of the caprazamycin biosynthetic pathway were synthesized and tested as substrates of Cpz4. Des-N-methyl-acyl-caprazol was converted with highest efficiency 100 times faster than phenol. The fatty acyl side chain and the uridyl moiety seem to be important for substrate recognition by Cpz4. Liponucleosides, partially purified from various mutant strains, were readily sulfated by Cpz4 using p-nitrophenol sulfate. No product formation could be observed with PAPS as the donor substrate. Sequence homology of Cpz4 to the previously examined ASSTs is low. However, numerous orthologs are encoded in microbial genomes and represent interesting subjects for future investigations.


Subject(s)
Anti-Bacterial Agents/chemistry , Arylsulfotransferase/chemistry , Nucleosides/chemistry , Streptomyces coelicolor/enzymology , Anti-Bacterial Agents/biosynthesis , Arylsulfotransferase/biosynthesis , Arylsulfotransferase/genetics , Arylsulfotransferase/isolation & purification , Catalysis , Cloning, Molecular , Nucleosides/biosynthesis , Recombinant Proteins/biosynthesis , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/isolation & purification , Sequence Homology, Amino Acid , Streptomyces coelicolor/genetics , Substrate Specificity
7.
J Biosci Bioeng ; 109(3): 230-4, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20159569

ABSTRACT

Highly reproducible production values of the aminocoumarin antibiotic novobiocin were achieved by cultivation of a heterologous Streptomyces producer strain in commercially available square deepwell plates consisting of 24 wells of 3 ml culture volume each. Between parallel cultivation batches in the deepwell plates, novobiocin accumulation showed standard deviations of 4-9%, compared to 39% in baffled Erlenmeyer flasks. Mycelia used as inoculum could be frozen in the presence of 20% peptone and stored at -70 degrees C, allowing repeated cultivations from the same batch of inoculum over extended periods of time. Originally, novobiocin titers in the deepwell plate (5-12 mg l(-1)) were lower than in Erlenmeyer flasks (24 mg l(-1)). Optimization of the inoculation procedure as well as addition of a siloxylated ethylene oxide/propylene oxide copolymer, acting as oxygen carrier, to the production medium increased novobiocin production to 54 mg l(-1). The additional overexpression of the pathway-specific positive regulator gene novG increased novobiocin production to 163 mg l(-1). Harvesting the precultures in a defined section of growth phase greatly reduced variability between different batches of inoculum. The use of deepwell plates may considerably reduce the workload and cost of investigations of antibiotic biosynthesis in streptomycetes and other microorganisms due to the high reproducibility and the low requirement for shaker space and culture medium.


Subject(s)
Anti-Bacterial Agents/biosynthesis , Bioreactors/microbiology , Cell Culture Techniques/instrumentation , Novobiocin/biosynthesis , Streptomyces/metabolism , Equipment Design , Equipment Failure Analysis , Streptomyces/cytology
9.
J Biol Chem ; 284(22): 14987-96, 2009 May 29.
Article in English | MEDLINE | ID: mdl-19351877

ABSTRACT

Caprazamycins are potent anti-mycobacterial liponucleoside antibiotics isolated from Streptomyces sp. MK730-62F2 and belong to the translocase I inhibitor family. Their complex structure is derived from 5'-(beta-O-aminoribosyl)-glycyluridine and comprises a unique N-methyldiazepanone ring. The biosynthetic gene cluster has been identified, cloned, and sequenced, representing the first gene cluster of a translocase I inhibitor. Sequence analysis revealed the presence of 23 open reading frames putatively involved in export, resistance, regulation, and biosynthesis of the caprazamycins. Heterologous expression of the gene cluster in Streptomyces coelicolor M512 led to the production of non-glycosylated bioactive caprazamycin derivatives. A set of gene deletions validated the boundaries of the cluster and inactivation of cpz21 resulted in the accumulation of novel simplified liponucleoside antibiotics that lack the 3-methylglutaryl moiety. Therefore, Cpz21 is assigned to act as an acyltransferase in caprazamycin biosynthesis. In vivo and in silico analysis of the caprazamycin biosynthetic gene cluster allows a first proposal of the biosynthetic pathway and provides insights into the biosynthesis of related uridyl-antibiotics.


Subject(s)
Anti-Bacterial Agents/biosynthesis , Multigene Family , Nucleosides/biosynthesis , Streptomyces/genetics , Uridine/analogs & derivatives , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Azepines , Cloning, Molecular , Gene Deletion , Gene Expression Regulation, Bacterial/drug effects , Microbial Sensitivity Tests , Models, Biological , Multigene Family/drug effects , Mycobacterium phlei/drug effects , Nucleosides/chemistry , Nucleosides/pharmacology , Reproducibility of Results , Sequence Analysis, DNA , Streptomyces/drug effects , Uridine/biosynthesis , Uridine/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...